FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

37141811000001103: Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jun 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
221171000001117 Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
221181000001115 Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Nilotinib 50mg capsules true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Tasigna true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Nilotinib hydrochloride monohydrate true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nilotinib true Inferred relationship Existential restriction modifier
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) 120 capsule 3 x 40 capsules Has AMP True Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start